Kymera Therapeutics, Inc. (KYMR)
NASDAQ·Healthcare·Biotechnology
$86.08
+3.76%
Mkt Cap $6.33B
Analyst Ratings
Buy
10
Hold
0
Sell
0
Price Target (55 analysts)
$117.31
Range $90.00 – $138.00
Implied Upside
+36.3%
Consensus $117.31 vs current $86.08
NASDAQ·Healthcare·Biotechnology
$86.08
+3.76%
Mkt Cap $6.33B
Buy
10
Hold
0
Sell
0
Price Target (55 analysts)
$117.31
Range $90.00 – $138.00
+36.3%
Consensus $117.31 vs current $86.08